Albemarle Corp diskutieren
Albemarle Corp
WKN: 890167 / Symbol: ALB / Name: Albemarle / Aktie / Chemie / Mid Cap /
79,79 €
0,20 %
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Royal Bank of Canada from $157.00 to $128.00. They now have an "overweight" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Robert W. Baird from $127.00 to $102.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Bank of America Co. from $135.00 to $126.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at KeyCorp from $151.00 to $132.00. They now have an "overweight" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $111.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Piper Sandler from $95.00 to $90.00. They now have an "underweight" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Evercore ISI from $190.00 to $170.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Neueste Beiträge
BTIG_Research in Integra LifeSciences Holdings Corp diskutieren